Cargando…
Bone metastases from neuroendocrine tumors: clinical and biological considerations
We considered 351 patients affected by neuroendocrine tumors (NETs), followed at the University Hospital of Padua and at the Veneto Oncological Institute. Of these, 72 (20.5%) suffered from bone metastases. The sample was divided according to the timing of presentation of bone metastases into synchr...
Autores principales: | Scopel, Matteo, De Carlo, Eugenio, Bergamo, Francesca, Murgioni, Sabina, Carandina, Riccardo, Cervino, Anna Rita, Burei, Marta, Vianello, Federica, Zagonel, Vittorina, Fassan, Matteo, Vettor, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254287/ https://www.ncbi.nlm.nih.gov/pubmed/35671272 http://dx.doi.org/10.1530/EC-21-0568 |
Ejemplares similares
-
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
por: Loupakis, Fotios, et al.
Publicado: (2019) -
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
por: Pellino, Antonio, et al.
Publicado: (2019) -
Immunotherapy in Gastrointestinal Cancers
por: Procaccio, Letizia, et al.
Publicado: (2017) -
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
por: Pellino, Antonio, et al.
Publicado: (2021) -
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
por: Loupakis, Fotios, et al.
Publicado: (2021)